These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33813355)

  • 1. Temocillin susceptibility among Enterobacterales strains recovered from blood culture in France.
    Farfour E; Si Larbi AG; Cattoir V; Corvec S; Guillard T; Grillon A; Isnard C; Mérens A; Degand N; Billard-Pomares T; Fournier D; Bille E; Le Brun C; Plouzeau C; Flevin E; Yin N; Woerther PL; Lourtet J; Lesprit P; Le Monnier A;
    Diagn Microbiol Infect Dis; 2021 Jul; 100(3):115368. PubMed ID: 33813355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong.
    Ip M; Lai CK; Fung KSC; Wong KT; Zhu C; Van de Velde S; Tsang DN; Hawkey P
    Eur J Clin Microbiol Infect Dis; 2017 Dec; 36(12):2491-2494. PubMed ID: 28840351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units.
    Glupczynski Y; Huang TD; Berhin C; Claeys G; Delmée M; Ide L; Ieven G; Pierard D; Rodriguez-Villalobos H; Struelens M; Vaneldere J
    Eur J Clin Microbiol Infect Dis; 2007 Nov; 26(11):777-83. PubMed ID: 17668253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temocillin susceptibility in Enterobacterales with an ESBL/AmpC phenotype.
    Kresken M; Pfeifer Y; Werner G
    Int J Antimicrob Agents; 2021 Jan; 57(1):106223. PubMed ID: 33166691
    [No Abstract]   [Full Text] [Related]  

  • 5. Temocillin against Enterobacteriaceae isolates from community-acquired urinary tract infections: low rate of resistance and good accuracy of routine susceptibility testing methods.
    Alexandre K; Réveillon-Istin M; Fabre R; Delbos V; Etienne M; Pestel-Caron M; Dahyot S; Caron F
    J Antimicrob Chemother; 2018 Jul; 73(7):1848-1853. PubMed ID: 29635629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temocillin versus carbapenems for urinary tract infection due to ESBL-producing Enterobacteriaceae: a multicenter matched case-control study.
    Delory T; Gravier S; Le Pluart D; Gaube G; Simeon S; Davido B; Piet E; Lepeule R; Lesprit P; Lafaurie M
    Int J Antimicrob Agents; 2021 Jul; 58(1):106361. PubMed ID: 34000372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of temocillin against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urinary tract infections in France.
    Duployez C; Loïez C; Cattoen C; Wallet F; Vachée A
    Med Mal Infect; 2019 Feb; 49(1):47-53. PubMed ID: 30396720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ceftriaxone and temocillin on fecal abundance of extended-spectrum β-lactamase producing Escherichia coli in a mouse model.
    Chenouard R; Mahieu R; Luque Paz D; Marion E; Eveillard M; Dubée V
    PLoS One; 2021; 16(3):e0248177. PubMed ID: 33690674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to penicillin derivatives among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
    Mischnik A; Baumert P; Hamprecht A; Rohde A; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV;
    Diagn Microbiol Infect Dis; 2017 Jan; 87(1):71-73. PubMed ID: 27769572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal evolution of temocillin susceptibility to Enterobacterales in Belgian hospitals, comments on 'Temocillin susceptibility among Enterobacterales strains recovered from blood culture in France'.
    Miendje Deyi VY; Nonhoff C; Hallin M; Martiny D
    Diagn Microbiol Infect Dis; 2022 Jun; 103(2):115682. PubMed ID: 35421759
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England.
    Livermore DM; Hope R; Fagan EJ; Warner M; Woodford N; Potz N
    J Antimicrob Chemother; 2006 May; 57(5):1012-4. PubMed ID: 16531428
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evolution of third-generation cephalosporin resistance in Enterobacteriaceae from 2000 to 2008 in a Perpignan hospital].
    Mayoral G; Ferreyra M; Eden A; Gueudet P; Miquel C; Lecaillon E
    Pathol Biol (Paris); 2010 Feb; 58(1):7-10. PubMed ID: 19854588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of third generation cephalosporin resistant Enterobacteriaceae from retail meats and detection of extended spectrum beta-lactamase activity.
    Rao M; Laidlaw A; Li L; Young K; Tamber S
    J Microbiol Methods; 2021 Oct; 189():106314. PubMed ID: 34461553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae.
    Balakrishnan I; Awad-El-Kariem FM; Aali A; Kumari P; Mulla R; Tan B; Brudney D; Ladenheim D; Ghazy A; Khan I; Virgincar N; Iyer S; Carryn S; Van de Velde S
    J Antimicrob Chemother; 2011 Nov; 66(11):2628-31. PubMed ID: 21810837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
    Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
    Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the
    Viala B; Zaidi FZ; Bastide M; Dumont Y; Le Moing V; Jean-Pierre H; Godreuil S
    Microb Drug Resist; 2019 Nov; 25(9):1325-1329. PubMed ID: 31225764
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
    Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
    J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Lactams without a suicide inhibitor.
    Giamarellou H
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():194-7. PubMed ID: 18154547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) - Data of a prospective traveller study.
    Kantele A; Mero S; Kirveskari J; Lääveri T
    Travel Med Infect Dis; 2017; 16():23-30. PubMed ID: 28153711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae.
    Hartl R; Widhalm S; Kerschner H; Apfalter P
    Clin Microbiol Infect; 2013 May; 19(5):E230-2. PubMed ID: 23397897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.